Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism Study of Finerenone in Diabetic Kidney Disease
ChiCTR2400086830Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of finerenone in diabetic glomerulosclerosis (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Urinary albumin-to-creatinine ratio (UACR) and Estimated glomerular filtration rate (eGFR). Planned start Jul 2024; status: not yet recruiting.
02
Drugs
finerenone
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR2400086830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086830.